Nothing Special   »   [go: up one dir, main page]

SG10202107054TA - Methods of detection and removal of rhabdoviruses from cell lines - Google Patents

Methods of detection and removal of rhabdoviruses from cell lines

Info

Publication number
SG10202107054TA
SG10202107054TA SG10202107054TA SG10202107054TA SG10202107054TA SG 10202107054T A SG10202107054T A SG 10202107054TA SG 10202107054T A SG10202107054T A SG 10202107054TA SG 10202107054T A SG10202107054T A SG 10202107054TA SG 10202107054T A SG10202107054T A SG 10202107054TA
Authority
SG
Singapore
Prior art keywords
rhabdoviruses
removal
detection
methods
cell lines
Prior art date
Application number
SG10202107054TA
Other languages
English (en)
Inventor
Joel Haynes
Original Assignee
Takeda Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc
Publication of SG10202107054TA publication Critical patent/SG10202107054TA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04Inactivation or attenuation; Producing viral sub-units
    • C12N7/045Pseudoviral particles; Non infectious pseudovirions, e.g. genetically engineered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5258Virus-like particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20021Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20051Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20051Methods of production or purification of viral material
    • C12N2760/20052Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/16011Caliciviridae
    • C12N2770/16023Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG10202107054TA 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines SG10202107054TA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361886438P 2013-10-03 2013-10-03

Publications (1)

Publication Number Publication Date
SG10202107054TA true SG10202107054TA (en) 2021-08-30

Family

ID=52779185

Family Applications (3)

Application Number Title Priority Date Filing Date
SG11201602585XA SG11201602585XA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines
SG10202107054TA SG10202107054TA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines
SG10201802772YA SG10201802772YA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201602585XA SG11201602585XA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10201802772YA SG10201802772YA (en) 2013-10-03 2014-10-03 Methods of detection and removal of rhabdoviruses from cell lines

Country Status (9)

Country Link
US (4) US10501500B2 (ko)
EP (1) EP3052631B1 (ko)
JP (6) JP2016533172A (ko)
KR (2) KR102474663B1 (ko)
CN (1) CN106103720A (ko)
AU (3) AU2014329403B2 (ko)
CA (1) CA2926225A1 (ko)
SG (3) SG11201602585XA (ko)
WO (1) WO2015051255A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140200831A1 (en) * 2011-01-28 2014-07-17 Schlumberger Technology Corporation Pipe Damage Interpretation System
SG11201602585XA (en) 2013-10-03 2016-05-30 Takeda Vaccines Inc Methods of detection and removal of rhabdoviruses from cell lines
WO2016115484A1 (en) * 2015-01-16 2016-07-21 Takeda Vaccines, Inc. Detection of particle-contained reverse transcriptase activity
PT3265121T (pt) 2015-03-05 2020-08-31 Boehringer Ingelheim Animal Health Usa Inc Sistema de marcadores, em particular para antígenos de subunidade expressos por baculovirus
CN104962580B (zh) * 2015-06-30 2018-04-27 浙江大学 一种重组植物弹状病毒载体及其构建方法
JP7272792B2 (ja) 2015-11-01 2023-05-12 グライコバック エルエルシー ウイルスフリーの細胞株及びそれを取得する方法
CN109182277B (zh) * 2018-09-07 2021-05-07 中国水产科学研究院长江水产研究所 一种黄鳝弹状病毒CrERV及RT-PCR检测引物及应用
WO2021158878A1 (en) 2020-02-06 2021-08-12 Boehringer Ingelheim Animal Health USA Inc. Polypeptides useful for detecting anti-rhabdovirus antibodies
EP4103699A1 (en) * 2020-02-10 2022-12-21 BioMarin Pharmaceutical Inc. Virus-free cell cultures
CN114686599A (zh) * 2020-12-30 2022-07-01 北京五加和基因科技有限公司 宿主昆虫细胞dna残留含量定量检测方法及试剂盒
JP2024519800A (ja) 2021-05-21 2024-05-21 タケダ ワクチン,インコーポレイテッド 固体組成物、フリーズドライ方法およびガラスバイアル

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024947A (en) 1987-07-24 1991-06-18 Cetus Corporation Serum free media for the growth on insect cells and expression of products thereby
JP3500602B2 (ja) 1998-03-31 2004-02-23 株式会社エスキューブ 盗難防止タグ
US6103526A (en) 1998-10-08 2000-08-15 Protein Sciences Corporation Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using
KR101119448B1 (ko) * 2002-09-11 2012-03-15 추가이 세이야쿠 가부시키가이샤 단백질 정제 방법
DK2066354T3 (da) 2006-09-29 2013-05-27 Ligocyte Pharmaceuticals Inc Norovirus vaccine formuleringer
CA2683977C (en) 2007-03-14 2017-04-25 Ligocyte Pharmaceuticals, Inc. A method of norovirus virus-like particle purification comprising ion exchange chromatography
CN101918028B (zh) 2007-09-18 2015-01-07 莱戈赛特医药股份有限公司 赋予针对诺如病毒的保护性免疫应答的疫苗
CN102177233B (zh) 2008-08-08 2015-04-15 莱戈赛特医药股份有限公司 用于增强交叉反应性的包含复合衣壳氨基酸序列的病毒样颗粒
JP2012506239A (ja) * 2008-10-20 2012-03-15 アボット・ラボラトリーズ Il−18に結合する抗体およびそれを精製する方法
EP2412817B2 (en) * 2009-03-27 2019-06-05 Asahi Kasei Medical Co., Ltd. Method for removing viruses in high-concentration monoclonal antibody solution
BR112014000656A2 (pt) 2011-07-11 2017-02-14 Takeda Vaccines Inc formulações de vacina parenteral contra norovírus
CN102605106B (zh) * 2012-03-29 2013-09-04 浙江省检验检疫科学技术研究院 蚕微孢子虫、核型多角体病毒和浓核病毒的三重荧光pcr检测方法及试剂盒和引物、探针
JOP20130186B1 (ar) 2012-06-22 2021-08-17 Takeda Vaccines Montana Inc تنقية الجزيئات الشبيهة بالفيروسات
SG11201602585XA (en) 2013-10-03 2016-05-30 Takeda Vaccines Inc Methods of detection and removal of rhabdoviruses from cell lines
JP7272792B2 (ja) 2015-11-01 2023-05-12 グライコバック エルエルシー ウイルスフリーの細胞株及びそれを取得する方法
CN114807009A (zh) 2022-03-28 2022-07-29 成都纳微金生物技术有限公司 一种不依赖血清的无弹状病毒污染的sf9细胞株、筛选方法及应用

Also Published As

Publication number Publication date
AU2020294216A1 (en) 2021-01-28
US20230303633A1 (en) 2023-09-28
KR102474663B1 (ko) 2022-12-07
JP2023024506A (ja) 2023-02-16
JP2024050747A (ja) 2024-04-10
US12018052B2 (en) 2024-06-25
JP2020036613A (ja) 2020-03-12
JP7191175B2 (ja) 2022-12-16
EP3052631A1 (en) 2016-08-10
AU2020294216B2 (en) 2022-11-24
JP2016533172A (ja) 2016-10-27
US12006341B2 (en) 2024-06-11
JP2022009010A (ja) 2022-01-14
SG11201602585XA (en) 2016-05-30
US11286282B2 (en) 2022-03-29
US20220213150A1 (en) 2022-07-07
WO2015051255A1 (en) 2015-04-09
US20160244487A1 (en) 2016-08-25
KR102649950B1 (ko) 2024-03-22
EP3052631A4 (en) 2017-06-14
AU2014329403A1 (en) 2016-05-05
CA2926225A1 (en) 2015-04-09
EP3052631B1 (en) 2019-08-07
AU2014329403B2 (en) 2020-10-08
SG10201802772YA (en) 2018-05-30
US20200190146A1 (en) 2020-06-18
CN106103720A (zh) 2016-11-09
JP2023126495A (ja) 2023-09-07
KR20160062049A (ko) 2016-06-01
AU2022259826A1 (en) 2023-01-19
US10501500B2 (en) 2019-12-10
KR20210154988A (ko) 2021-12-21

Similar Documents

Publication Publication Date Title
HK1219975A1 (zh) 用於病毒生產的細胞系和使用方法
HK1217539A1 (zh) 使用工程轉導粒子檢測細胞的系統和方法
HK1220800A1 (zh) 顆粒檢測系統及相關方法
SG10202107054TA (en) Methods of detection and removal of rhabdoviruses from cell lines
EP2971279A4 (en) METHOD AND DEVICES FOR HIGH-PURGE CLEANING
EP2965479A4 (en) METHOD AND SYSTEMS FOR IMPROVED DETECTION OF E-NAVIGATION MESSAGES
GB201319105D0 (en) Detection apparatus and method
ZA201500394B (en) Methods of handling avocados and system
IL244274A0 (en) Device and methods for using the device for detecting hyperammonemia
GB201315185D0 (en) Location detection system and method
HK1215416A1 (zh) 分離裝置以及分離方法
HK1224256A1 (zh) 物體檢測系統以及用於操作物體檢測系統的方法
EP2998901A4 (en) DETECTION SYSTEM FOR UNAUTHORIZED ACCESS AND METHOD FOR DETECTING UNAUTHORIZED ACCESS
EP2948566A4 (en) CHROMOPHORE-BASED CHARACTERIZATION AND DETECTION METHODS
GB2513304B (en) Peripheral apparatus and method of construction
HRP20181974T1 (hr) Postupak i sustav za igru
EP2971257A4 (en) SYSTEMS AND METHOD FOR PROTECTING ELECTROLYSIS CELL SIDE WALLS
IL245272A0 (en) pif-transfected cells and methods of use
GB201319099D0 (en) Detection apparatus and method
HK1207449A1 (en) Methods and apparatus for efficient execution of modules
IL227948A0 (en) Methods and systems for desalination and washing
IL240309B (en) A system and method for processing agricultural produce
SG11201605386TA (en) Uni-directional rigidifier and method
GB201306810D0 (en) Methods of cell separation
GB2513388B (en) Improved dock bumper and method of replacement